RxDoctor Payments Data

William Sheaffer, MD

Vascular Surgery · Duluth, MNNPI 1750768388

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 31.0% of the total. Reporting peaked in 2022 at $4,130 and has fallen 97.0% since, to $123 in 2025.

$8,473in general payments, 2019–2025

Across 58 payments — averaging $146.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$3K
  • Cook Medical LLC$2K
  • Silk Road Medical, Inc.$2K
  • Terumo Medical Corporation$1K
  • Bolton Medical Inc$572
  • Shockwave Medical, Inc$160
  • plus $244 from 5 others

What the payments were for

  • Grants$1,39416%
  • Travel & lodging$3,32739%
  • Food & beverage$2,87934%
  • Education$87410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,473 in reported general payments places this provider in the 70th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$95,303
Medicare patients
315
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate132$1,715
Atorvastatin Calcium65$735
Cilostazol13$157
Oxycodone Hcl15$32

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Duluth

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →